Xcout IntelSign inSubscribe

Xanadu Bio, Inc.

BiotechnologyGladwyne, PA, United States

Xanadu Bio, Inc. is a biotechnology company that develops next-generation polymer nanoparticle delivery platforms for mRNA and other nucleic acid-based therapies. Utilizing its proprietary poly(amine-co-ester) (PACE) polymer technology, the company creates tunable, organ-specific treatments for oncology and immunology, as well as intranasal vaccines for viral respiratory pathogens.

Subscribe to see Xanadu Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Xanadu Bio, Inc. at a glance

Xanadu Bio, Inc. is a biotechnology company headquartered in Gladwyne, United States. Its most recent funding round raised $11M in August 2025. Xcout tracks 13 named people at Xanadu Bio, Inc., including Bruce Turner (Chief Executive Officer & President of the Issuer).

As of 16 November 2026. Source: Xcout Intel.

Industry
Biotechnology
Headquarters
Gladwyne, PA, United States

Xanadu Bio, Inc. leadership

  • Bruce TurnerChief Executive Officer & President of the Issuer
  • Bruce Turner, M.D., Ph.D.Chief Executive Officer, Co-founder, and Chairman
  • Taylor Feehley, Ph.D.Chief Operating Officer
  • Todd Wider, M.D.Chief Medical Officer, Co-Founder, and Member of Board
  • Akiko Iwasaki, Ph.D.Co-founder
  • Alexandra Piotrowski-Daspit, Ph.D.Co-founder

7 more named people on record for Xanadu Bio, Inc., with roles, board committees and tenure — see the full roster →

Xanadu Bio, Inc. funding rounds

Every round on record:

DateRoundAmountInvestors
SEC Form D filing$11M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Xanadu Bio, Inc. competitors

A few of Xanadu Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →

Get Xanadu Bio, Inc.'s news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Something wrong or missing about Xanadu Bio, Inc.? Suggest a correction · Work at Xanadu Bio, Inc.? Claim this profile

Is this your company? Add the Xcout Intel badge to your website

Free, for any company on Xcout Intel. It links visitors to this profile.

Xanadu Bio, Inc. on Xcout Intel

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Xanadu Bio, Inc. — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Xanadu Bio, Inc. in Xcout Intel

  • 13 named people with titles, LinkedIn and board committees
  • 1 funding round with the investors in each, and who they co-invest with
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →